Health in a Hurry: The Week’s Important Medical & Pharma News

Welcome to another edition of Health in a Hurry, our quick tour through medical news you might otherwise miss. This week we look at a respiratory virus many people have never heard of, a long-awaited generic asthma inhaler, a push to teach medical students more about nutrition, and a worrisome new study examining cancer deaths near nuclear power plants.

A Respiratory Virus in a Hurry: Beware Human Metapneumovirus (HMPV)

Human metapneumovirus (HMPV) isn’t new, but it’s suddenly getting more attention because cases are rising in California and New Jersey. We would be surprised if this virus is not widespread in a lot of other states. We pay a lot of attention to WastewaterSCAN. It monitors pathogens in sewage and is currently showing HMPV at high levels from Texas to Minnesota and east to Virginia and Delaware.

The virus was first identified in 2001, but most people have never heard of it. Like RSV, influenza and COVID-19, HMPV spreads through respiratory droplets, contaminated surfaces and close contact with infected people. Wastewater surveillance now shows elevated levels in several Northern California communities including San Francisco, Sacramento and Santa Rosa.

Symptoms resemble a typical winter respiratory illness: cough, nasal congestion, fever and sometimes shortness of breath. In most people the infection causes mild illness that resolves within a week. But HMPV can occasionally progress to bronchitis or pneumonia, particularly in young children, older adults and people with weakened immune systems.

National surveillance data from the CDC suggest the virus now accounts for just over 5 percent of positive respiratory virus tests in the U.S., and activity typically rises through late winter and spring.

If you would like to know what to do, we have nothing to offer. Unlike flu or COVID-19, there is no vaccine and no specific antiviral treatment for HMPV. Doctors generally recommend supportive care—rest, fluids and medications to relieve symptoms. Severe cases may require oxygen therapy or hospital care.

Why This Matters

Most Americans are familiar with flu, RSV and COVID. HMPV is another reminder that respiratory virus season rarely involves just one germ. Several viruses often circulate at the same time, and they can infect people simultaneously.

The prevention advice will sound familiar: wash hands, avoid close contact with sick people, improve indoor air quality and stay home when ill. These simple steps remain the best defense against a virus many people have never heard of—but may soon encounter. You may want to listen to our interview with Dr. Seheult. He specializes in pulmonary diseases and critical care medicine and provides insights into natural approaches to improve immune responses to respiratory infections. Here is a link.

Show 1457: How to Strengthen Your Immune System for Cold and Flu Season

Nuclear Power in a Hurry: Do Nearby Residents Face Higher Cancer Risk?

A large new nationwide study has raised unsettling questions about whether people who live near nuclear power plants face a higher risk of dying from cancer.

Researchers from the Harvard T.H. Chan School of Public Health analyzed cancer mortality data from every U.S. county between 2000 and 2018 and compared it with proximity to nuclear power plants. Their findings, published in Nature Communications (Feb. 23, 2026), suggest that counties located closer to operating nuclear plants had higher cancer death rates than counties farther away.

The investigators estimate that roughly 115,000 cancer deaths over the 19-year study period (about 6,400 annually) were statistically associated with living nearer to nuclear facilities.

Unlike many earlier studies that examined just one plant at a time, the researchers used a method called “continuous proximity.” This approach considered the combined influence of multiple nuclear plants within about 200 kilometers of a county.

Even after adjusting for many factors known to influence cancer risk (such as smoking rates, obesity, income, education, race and access to health car), the association between proximity and cancer mortality remained.

The researchers stress an important point: this study does not prove that nuclear plants cause cancer. The analysis relied on geographic proximity rather than direct measurements of radiation exposure.

Why This Matters

Ionizing radiation is a well-established carcinogen. But scientists have long debated whether the low levels of radiation potentially released from normal nuclear power plant operations are sufficient to affect cancer risk in surrounding communities.

This new nationwide analysis cannot answer that question definitively. It does, however, suggest that the relationship deserves deeper investigation, especially since millions of Americans live within a few dozen miles of nuclear reactors.

Before anyone panics, remember that the study found a statistical association, not proof of cause and effect. When it comes to radiation exposure, though, even small risks can become important when millions of people are involved.

If nuclear power is going to play a larger role in future energy policy, regulators and researchers will need better data about potential long-term health effects for people living nearby.

Nutrition in a Hurry: Medical Schools Promise More Training on Food and Health

For decades patients have complained that many physicians know surprisingly little about nutrition. Now there may be a shift underway.

This week, 53 medical schools in 31 states announced plans to expand nutrition education in their curricula. The initiative, supported by the Department of Health and Human Services, aims to ensure that medical students receive about 40 hours of nutrition-related training beginning in fall 2026.

Participating schools have agreed to review their existing curriculum, appoint a faculty leader to champion nutrition education, and publish a public plan outlining how they will expand instruction.

The push reflects growing concern about chronic illnesses such as obesity, diabetes and heart disease—conditions strongly influenced by diet. Currently, fewer than one-third of medical students receive even 25 hours of nutrition training, the level long recommended by the National Research Council.

Medical organizations including the American Medical Association and the Association of American Medical Colleges have expressed support for strengthening nutrition education, though some experts emphasize that physicians should still rely heavily on registered dietitians for specialized dietary counseling.

Why This Matters

Doctors frequently treat many diseases linked to diet: diabetes, high blood pressure, obesity and heart disease. Sadly, many physicians report feeling poorly prepared to discuss nutrition with patients.

Expanding nutrition education could help doctors feel more comfortable addressing diet as part of routine medical care. Still, education alone may not solve the problem. Physicians often have only 10 to 15 minutes with a patient, hardly enough time for detailed dietary counseling.

We highly recommend a book written by a frequent guest on The People’s Pharmacy radio show, Dr. Tieraona Low Dog. In our opinion, her book, Fortify Your Life: Your Guide to Vitamins, Minerals and More, is one of the best resources for nutrition you can find. While you are at it, why not listen to our interview with Dr. Low Dog at this link. We think you will be better informed about nutrition after listening and reading Dr. Low Dog’s work than your doctor is.

Show 1124: Should You Be Taking Vitamin Supplements?

Asthma Inhalers in a Hurry: A “True” Generic Flovent Finally Arrives

After two years of confusion and controversy surrounding the asthma inhaler Flovent, the FDA has approved the first “true” generic version of the medication.

The drug, fluticasone propionate inhalation aerosol, is an inhaled corticosteroid used for long-term asthma control in adults and children. It works by reducing inflammation in the airways, helping prevent wheezing and shortness of breath.

The approval comes after a bizarre period for asthma patients. At the beginning of 2024, GlaxoSmithKline abruptly discontinued the branded versions of Flovent. But here is where it gets super confusing. GSK continued to make this inhaler but another company, Prasco Laboratories, sold it as an “authorized generic” containing the same exact fluticasone ingredient as the original branded product.

It was the same product with a different label distributed through another company. Critics argued that the move created insurance disruptions and left some patients scrambling to find affordable alternatives.

Now the drugmaker Glenmark Pharmaceuticals has received FDA approval for what regulators describe as the first independent generic version of the Flovent inhaler. Because Glenmark was first to market, it receives 180 days of exclusivity before other generic competitors can enter the market.

The company says the inhaler should begin reaching pharmacies this month.

Why This Matters

Asthma affects millions of adults and children. Inhaled corticosteroids such as fluticasone are considered an effective way to prevent asthma attacks and reduce hospitalizations.

When Flovent disappeared from pharmacy shelves in 2024, many patients were forced to switch medications, sometimes because their insurance companies refused to cover alternatives.

A widely available generic could lower costs and improve access. But asthma specialists caution that inhalers are not always interchangeable, and patients should talk with their clinician before switching devices or medications.

We are all for authorized generic drugs because they offer identical quality as the brand name version. In the case of Flovent the original manufacturer continued to supply the medicine. We can only hope that the FDA’s oversight of the Glenmark product is every bit as good as the product that Prasco has been selling.

You can read more about authorized generic pharmaceuticals at this link.

Final Words:

These short takes are our attempt to highlight important health stories that don’t always make the front page. Let us know if Health in a Hurry helps you stay on top of the news—or if there are topics you’d like us to cover next.